Document is current
Any future updates will be listed below
-
Authors
Wang, Z.
Bi, H.
Wang, Y.D.
Liu, Q.
Shao, B.
Li, C.Q.
Fu, C.
Fu, S.
Shan, G.Y.
Chen, A.
Lv, C.C.
Zeng, Y.
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Tislelizumab, un nuevo anticuerpo monoclonal anti-PD-1 para el cáncer urotelial: estudio de vida real
Journal Title: Actas Urológicas Españolas
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuro.2023.10.010
Content Type: article
Copyright: © 2023 Published by Elsevier España, S.L.U. on behalf of AEU.
